FDA Clearance Tracker · P120023
KAMRA INLAY
Last checked: Nov 19, 2026Latest source record: Apr 17, 2015 (this decision)Source: openFDAMethods & limitations
Decided
Apr 17, 2015
Approval withdrawn
Time to decision
856 days
Received Dec 12, 2012. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P120023
- Device name
- KAMRA INLAY
- Applicant
- Corneagen
- Applicant location
- Seattle, WA
- Received
- Dec 12, 2012
- Decided
- Apr 17, 2015
- Decision
- Approval withdrawn
- Supplements
- 4 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Implant, corneal, refractive (LQE)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE KAMRA INLAY. THE KAMRA INLAY IS INDICATED FOR INTRASTROMAL CORNEAL IMPLANTATION TO IMPROVE NEAR VISION BY EXTENDING THE DEPTH OF FOCUS IN THE NON-DOMINANT EYE OF PHAKIC, PRESBYOPIC PATIENTS BETWEEN THE AGES OF 45 AND 60 YEARS OLD WHO HAVE CYCLOPLEGIC REFRACTIVE SPHERICAL EQUIVALENT OF +0.50 D TO -0.75 D WITH LESS THAN OR EQUAL TO 0.75 D OF REFRACTIVECYLINDER, WHO DO NOT REQUIRE GLASSES OR CONTACT LENSES FOR CLEAR DISTANCE VISION, AND WHO REQUIRE NEAR CORRECTION OF +1.00 D TO +2.50 D OF READING ADD.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LQE. The earliest in FDA's data is P980031, decided Apr 9, 1999.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Corneagen
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- EndoSerter-PL510(k)
K203586 · Decided Feb 2, 2022 · 421 days after receipt
Device type: Graft Insertion Instrument For Endothelial Keratoplasty (OTZ) · Ophthalmology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.